|
⚲
|
| Keyboard |
| GSK PLC
✚
|
|
|---|---|
| CIK # | 0001131399 |
| CIK | Period |
|---|---|
| 0001131399 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| CRISPR Therapeutics AG | 153.2 | ||
| Wave Life Sciences Ltd | 132.3 | ||
| Biontech SE | 79.1 | ||
| VIR Biotechnology Inc | 76.6 | ||
| IDEAYA Biosciences Inc | 44.4 | ||
| Lyell Immunopharma Inc | 30.3 | ||
| Cytokinetics Inc | 22.4 | ||
| Spero Therapeutics Inc | 21.5 | ||
| Fulcrum Therapeutics Inc | 13.7 | ||
| CVRX Inc | 9.5 | ||
| Bicycle Therapeutics PLC | 7.1 | ||
| Nkarta Inc | 6.6 | ||
| RegenxBio Inc | 2.3 | ||
| Prev | Page 1 | Next | |||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001131399] | |
| 3 | [0001131399] | |
| 4 | [0001131399] | |
| 5 | [0001131399] | |
| 6-K | [0001131399] | |
| SC 13D | [0001131399] | |
| SC 13G | [0001131399] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Wave Life Sciences Pte Ltd WVE
Ordinary Shares
|
2025-12-11 | Buy | 1,470,000 | $19.00 | 27,930,000 |
|
Wave Life Sciences Pte Ltd WVE
Ordinary Shares
|
2024-09-27 | Buy | 2,791,930 | $8.00 | 22,335,440 |
|
Wave Life Sciences Pte Ltd WVE
Ordinary Shares
|
2023-12-07 | Buy | 3,300,000 | $5.00 | 16,500,000 |
|
Theravance Biopharma Inc TBPH
Ordinary Shares
|
2022-09-16 | Other | 9,644,807 | $9.75 | 94,036,868 |
|
Theravance Biopharma Inc TBPH
Exchangeable Senior Notes due 2023 · derivative
|
2022-09-16 | Other | |||
|
CVRx Inc CVRX
Common Stock
|
2021-07-02 | Conversion | 27,345 | ||
|
CVRx Inc CVRX
Common Stock
|
2021-07-02 | Conversion | 635,646 | ||
|
CVRx Inc CVRX
Series D-2 Preferred Stock · derivative
|
2021-07-02 | Conversion | 589,939 | $0.00 | |
|
CVRx Inc CVRX
Series G Preferred Stock · derivative
|
2021-07-02 | Conversion | 10,055,408 | $0.00 | |
|
CVRx Inc CVRX
Series F-2 Preferred Stock · derivative
|
2021-07-02 | Conversion | 1,081,434 | $0.00 | |
|
CVRx Inc CVRX
Series B-2 Preferred Stock · derivative
|
2021-07-02 | Conversion | 59,527 | $0.00 | |
|
CVRx Inc CVRX
Series C-2 Preferred Stock · derivative
|
2021-07-02 | Conversion | 513,312 | $0.00 | |
|
CVRx Inc CVRX
Series E-2 Preferred Stock · derivative
|
2021-07-02 | Conversion | 331,399 | $0.00 | |
|
CVRx Inc CVRX
Common Stock
|
2021-07-02 | Conversion | 14,917 | ||
|
CVRx Inc CVRX
Common Stock
|
2021-07-02 | Conversion | 12,979 | ||
|
CVRx Inc CVRX
Common Stock
|
2021-07-02 | Conversion | 1,505 | ||
|
CVRx Inc CVRX
Common Stock
|
2021-07-02 | Conversion | 8,380 | ||
|
CVRx Inc CVRX
Common Stock
|
2021-07-02 | Buy | 275,000 | $18.00 | 4,950,000 |
|
Lyell Immunopharma Inc LYEL
Series AA Preferred Stock · derivative
|
2021-06-21 | Conversion | 30,253,189 | ||
|
Lyell Immunopharma Inc LYEL
Common Stock
|
2021-06-21 | Conversion | 30,253,189 | ||
| showing 20 of 190 most recent transactions | |||||